What is Mass General Brigham investing in? 21 companies in the health system’s portfolio

Boston-based Mass General Brigham has a large venture capital arm, Mass General Brigham Ventures, and has made some notable investments in the life sciences, biotech, medtech and digital health spaces.

Advertisement
Noah Schwartz

Here are 21 companies in Mass General’s portfolio:

 

  1. Abscuro
  2. Affinia Therapeutics
  3. Amolyt Pharma
  4. Claris Bio
  5. FireCyte Therapeutics
  6. Garuda Therapeutics
  7. InStride Health
  8. Lyndra Therapeutics
  9. Mediar Therapeutics
  10. Nocion Therapeutics
  11. Paros Bio
  12. Photys
  13. Pykus
  14. QurAlis
  15. Rippl Care
  16. ROME Therapeutics
  17. Scorpion Therapeutics
  18. SeQure Dx
  19. SwanBio Therapeutics
  20. Walden Biosciences
  21. Ziel Bio

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.